Results 141 to 150 of about 15,527,582 (268)

Cross-flow membrane filtration of cell suspensions

open access: yes, 1989
Thesis (Ph. D.)--Massachusetts Institute of Technology, Dept.
Ofsthun, Norma Jean
core  

Oncogenic DMTF1β promotes cancer cell motility by regulating autophagy through ULK1 stabilization

open access: yesMolecular Oncology, EarlyView.
In the current study, we demonstrate that the oncogene DMTF1β regulates ULK1 stability by reducing its proteasomal degradation in cancer cells. This stabilization enables ULK1 to induce autophagy, which in turn facilitates cancer cell migration. Consequently, reduced DMTF1β levels lead to decreased autophagy and impaired cancer cell migration.
Jun Xu   +13 more
wiley   +1 more source

Spatial and single‐nuclei transcriptomics reveals idiosyncratic and generic patterns in papillary and anaplastic thyroid cancers

open access: yesMolecular Oncology, EarlyView.
Matched spatial transcriptomics and single‐nuclei RNA‐seq were generated for anaplastic and BRAFV600E papillary thyroid cancers revealing generic and tumor‐specific states occurring in cancer cells and in the tumor microenvironment. In this context, cancer dedifferentiation mirrored organoid maturation through ordered thyroid marker gain/loss ...
Adrien Tourneur   +11 more
wiley   +1 more source

Catalytic oxidation of ethylene and propylene in a solid electrolyte cell

open access: yes, 1982
Thesis (Ph.D.)--Massachusetts Institute of Technology, Dept. of Chemical Engineering, 1982.MICROFICHE COPY AVAILABLE IN ARCHIVES AND SCIENCEIncludes bibliographical references.by Michael Stoukides.Ph ...
Stoukides, Michael
core  

Editorial: Innovators in chemistry: 2022

open access: yesFrontiers in Chemistry
Aleksandar Kondinski   +1 more
doaj   +1 more source

Inhibition of cyclin‐dependent kinases 12/13 using CT7439 as a treatment for colorectal cancer with CDK12 upregulation

open access: yesMolecular Oncology, EarlyView.
The proposed mechanism of action for the CDK12/13 inhibitor and cyclin K degrader, CT7439. CDK12/13 inhibition interrupts transcription elongation, leading to increased DNA damage that results in cell death. This agent is a potentially novel treatment option for patients with colorectal cancer. Created in BioRender. Cyclin‐dependent kinase (CDK) 12 and
Wylie K. Watlington   +10 more
wiley   +1 more source

XII International scientific-technical conference «High chemical technologies-2008»

open access: yesТонкие химические технологии, 2008
XII International scientific-technical conference is devoted to problems of: chemistry and technology of organic and inorganic materials, chemistry and technology medical products and biologically active substances, ecological and economic problems of ...
V. D. Yulovskaya, V. S. Timofeev
doaj  

In vitro and in silico modelling of ROS1‐positive non‐small cell lung cancer reveals fusion‐dependent tyrosine kinase inhibitor responses

open access: yesMolecular Oncology, EarlyView.
Drug resistance limits treatment success in a subset of lung cancers driven by ROS1 gene alterations. Using patient‐derived cells and computer simulations, we studied three key mutations and how they affect five targeted drugs. The mutations reduced drug effectiveness in different ways by altering protein structure and behavior.
Farhan Ul Haq   +8 more
wiley   +1 more source

Multiphase flow through spatially periodic models of porous media

open access: yes, 1989
Thesis (Ph. D.)--Massachusetts Institute of Technology, Dept. of Chemical Engineering, 1989.Includes bibliographical references (leaves 242-273).by Ludwig C.
Nitsche, Ludwig C. (Ludwig Carlos)
core  

Home - About - Disclaimer - Privacy